AbbVie and Genmab seek to expand use of T cell engager Epkinlynews2025-08-08T02:05:17+00:00August 8th, 2025|Endpoints News|
Gilead says it ‘hit the ground running’ on its long-acting HIV shot launchnews2025-08-08T01:57:40+00:00August 8th, 2025|Endpoints News|
Kennedy’s mRNA cuts challenge Trump’s Warp Speed achievementsnews2025-08-07T19:12:56+00:00August 7th, 2025|Endpoints News|
Dewpoint downsizes while in ‘final stages’ of getting more funds for first trialnews2025-08-07T19:09:44+00:00August 7th, 2025|Endpoints News|
UPDATED: Two courts reject arguments against IRA in win for governmentnews2025-08-07T18:55:49+00:00August 7th, 2025|Endpoints News|
New FDA program aims to speed up construction of US manufacturing sites news2025-08-07T15:45:47+00:00August 7th, 2025|Endpoints News|
Obesity pill comparison: How Novo, Lilly and others stack upnews2025-08-07T15:41:03+00:00August 7th, 2025|Endpoints News|
Strand Therapeutics nabs $153M to test mRNA cancer therapiesnews2025-08-07T15:19:17+00:00August 7th, 2025|Endpoints News|
J&J gets CRL over manufacturing issues; Charles River stays afloatnews2025-08-07T15:16:08+00:00August 7th, 2025|Endpoints News|
